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Abstract
Background:  Inserting transgenes into bacterial chromosomes is generally quite involved,
requiring a selection for cells carrying the insertion, usually for drug-resistance, or multiple
cumbersome manipulations, or both. Several approaches use phage λ red recombination, which
allows for the possibility of mutagenesis of the transgene during a PCR step.
Results: We present a simple, rapid and highly efficient method for transgene insertion into the
chromosome of Escherichia coli, Salmonella or Shigella at a benign chromosomal site using the site-
specific recombination machinery of the transposon Tn7. This method requires very few
manipulations. The transgene is cloned into a temperature-sensitive delivery plasmid and
transformed into bacterial cells. Growth at the permissive temperature with induction of the
recombination machinery leads to transgene insertion, and subsequent growth at the
nonpermissive temperature cures the delivery plasmid. Transgene insertion is highly site-specific,
generating insertions solely at the Tn7 attachment site and so efficient that it is not necessary to
select for the insertion.
Conclusion:  This method is more efficient and straightforward than other techniques for
transgene insertion available for E. coli and related bacteria, making moving transgenes from
plasmids to a chromosomal location a simple matter. The non-requirement for selection is
particularly well suited for use in development of unmarked strains for environmental release, such
as live-vector vaccine strains, and also for promoter-fusion studies, and experiments in which every
bacterial cell must express a transgene construct.
Background
Expression of transgenes in bacteria is routinely accom-
plished by expressing the gene from an extrachromosomal
plasmid. However, chromosomal expression, with its sin-
gle-copy nature and inherent stability, is preferable in
many situations. For example, in experiments where phys-
iological levels of protein are desired, including genetic
complementation experiments, even low copy number
plasmids can yield non-physiological levels of expression
making single-copy expression a better choice [1]. In addi-
tion, interpretation of experiments involving plasmids
can often be confounded by the heterogeneity of the pop-
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ulation arising from plasmid loss due to the imperfect seg-
regation of most plasmids [2]. Recent experiments in
Salmonella have shown that merely having a plasmid
present in a strain can have an effect on virulence [3]. An
additional difficulty with plasmids is that a selection is
required to maintain them during growth. Typically this is
provided by a drug-resistance (drugR) marker, however
drugR markers are undesirable in some contexts such as
when bacteria will be introduced into humans (e.g., for
live vaccine purposes [2]). Expression of transgenes from
the chromosome bypasses the sub-ideal features of plas-
mid-based expression. However, most systems for trans-
gene insertion are somewhat cumbersome, involving
multiple steps, and also require a drugR marker to allow
selection for relatively rare integration events [4,5]. Those
that do not involve drug selection rely on other selection
strategies that involve multiple steps [6]. We describe a
system that makes chromosomal transgene expression,
with all its advantages, and without need of a selection, so
simple to achieve that it can be routinely used.
We have developed a system for chromosomal transgene
insertion that does not require a selection for transgene
insertion based on the site-specific recombination system
of the bacterial transposon, Tn7. Tn7 uses five proteins for
transposition, TnsABCDE [7]. TnsA and TnsB form the
transposase that recognizes approximately 240 bp
sequences at the ends of Tn7 and does the breakage and
joining reactions of transposition, moving the transposon
into the new site. TnsD and TnsE are alternative site selec-
tors that determine where the transposon will insert, and
TnsC links TnsA and TnsB to the site selectors, activating
transposition through regulation of the ATP-bound state
of TnsC. TnsE mediates transposition into conjugative
plasmids, whereas TnsD promotes site-specific transposi-
tion into a chromosomal "safe haven" attachment site
(attTn7) at the 3' end of the glmS gene. TnsD recognizes a
site in the highly conserved glmS gene (essential in E. coli
[8] and likely essential in nearly all bacteria), and inserts
immediately downstream of glmS into attTn7, such that
no gene is disrupted, and at no discernable fitness cost to
the host [7]. In cells expressing TnsABCD, transposition
occurs exclusively into attTn7, and not into other loca-
tions [7]. Tn7 appears to have a broad host range, having
been demonstrated to function in many species of bacte-
ria [9].
Our overall strategy is as follows: tnsABCD and a trans-
gene flanked by recognition sites for the tranposase are
delivered into cells on a temperature-sensitive plasmid
that can later be cured. We use transformation (or conju-
gation) to establish a culture of plasmid-bearing cells,
induce expression of the TnsABCD proteins to promote
transposition into the attTn7 site, and then cure the plas-
mid. Using this strategy the majority of cells treated
acquire a transgene insertion at attTn7, as detailed below.
Results
Our integration system consists of a plasmid (pGRG25,
Figure 1) carrying two key components: a multiple clon-
ing site for transgene insertion flanked by the left and
right ends of Tn7, and the tnsABCD genes expressed under
control of the PBAD promoter [10]. tnsABCD are outside
the transposon ends, so that they will not be inserted into
the chromosome during transposition. The plasmid car-
ries  araC  to mediate arabinose-inducible expression of
tnsABCD genes, and a temperature-sensitive origin from
pSC101 [11] to allow curing of the plasmid after trans-
gene insertion. It also has a bla gene for plasmid selection,
and an origin of transfer, oriT, to allow delivery by conju-
gation.
Transposition vector Figure 1
Transposition vector. The vector pGRG25 contains a 
multiple cloning site (MCS) with unique restriction sites for 
AvrII, NotI, PacI, and XhoI, flanked by the terminal repeats of 
Tn7. Cloning of the gene of interest into these sites, in 
between the Tn7 arms, will result in a plasmid that can be 
used to insert the transgene into the chromosome. araC is 
the regulator of the arabinose-inducible promoter PBAD 
(though in all experiments presented, leaky expression was 
sufficient). tnsABCD are the genes required for transposition 
of Tn7. rrnD is the transcription terminator. bla encodes β-
lactamase which allows selection of ampicillin resistance 
when transforming the plasmid into bacteria. oriT is the RP4 
conjugal transfer origin. pSC101 ori ts is the temperature sen-
sitive origin of replication which functions at 32°C, but not at 
42°C. Vector pGRG36 is identical except for the addition of 
a SmaI site to the MCS. The sequence of pGRG25 and 
pGRG36 can be accessed at GenBank (accession # 
DQ460223).BMC Microbiology 2006, 6:39 http://www.biomedcentral.com/1471-2180/6/39
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Transgene insertions are generated as follows (Figure 2):
first a transgene is cloned into the multiple cloning site.
Then, the plasmid is introduced into cells by transforma-
tion or conjugation, and a population of cells carrying the
plasmid is established by selecting ampicillin resistance at
32°C on LB solid medium. These cells are then grown
non-selectively in LB medium. Some bacteria may require
arabinose induction of TnsABCD during this growth step,
but in E. coli leaky expression without induction by arab-
inose is sufficient. When the cultures are saturated, they
are plated on LB medium at 42°C for individual colonies
that are then screened for presence of the transgene by
PCR across attTn7. Table 1 shows that the majority (79%)
of colonies so isolated carry the transgene insertion at
attTn7. All colonies consisted of ampicillin-sensitive cells,
indicating that the plasmid was lost. Thus, the frequency
of insertion is high enough that a selection is not required
to identify insertions.
Recombination mediated by TnsABCD is well docu-
mented to yield Tn7 insertion only at attTn7 [7], suggest-
ing that in this system cells should not acquire a transgene
at sites other than attTn7. However, to confirm this, we
assayed for insertion events at other sites as follows. We
used a chloramphenicol-resistant (ChlR) transgene to
allow selection for all insertion events and selected ChlR
cells directly. We find that, after the procedure described
above, 79 ± 8% of cells in a culture are ChlR (Table 2). This
is comparable to the frequency of Tn7  insertion into
attTn7 (determined by PCR) when no selection is applied
(Table 1). All ChlR colonies tested (9/9) carry the mini-
Tn7 at the attachment site (determined by PCR, data not
shown). We conclude that TnsABCD are delivering the
Tn7 specifically to attTn7, as expected from the many stud-
ies of Tn7  site-specific recombination, though our fre-
quency of 79% is a much higher frequency than the 10-2
reported previously using other in vivo Tn7 transposition
assays [12].
Although the above experiment confirms that insertion is
specific to attTn7, we wanted to further ensure that this
system was not promoting insertions at other sites, given
the extraordinary frequency of transposon insertion
observed. To detect rare non-attTn7 insertion events, we
made use of a property of Tn7 known as transposition
immunity whereby Tn7 blocks transposition into a site
already occupied by a Tn7 [13]. We compared the ability
of our system to deliver a ChlR transgene into a pair of
strains, one with Tn7 already in the attachment site (to
measure non-specific transposition frequencies) and one
without Tn7  (to measure integration frequencies at
attTn7). Selecting for the ChlR transgene, we found that
the frequency of insertion (ChlR cells) was nearly 104 fold
lower in the strain with a blocked attachment site (Table
2). Thus insertion at secondary sites can occur but the fre-
quency is so much lower that it is extremely unlikely to
recover a secondary non-site-specific insertion (approxi-
mately 1/104 isolated colonies will carry an insertion at a
site other than attTn7).
Discussion & conclusion
This system for creating chromosomal transgenes is fast,
easy and efficient. Transposition occurs in 79% of cells
treated (Table 1), and occurs very specifically into the Tn7
attachment site. This is the highest Tn7 transposition seen
in any in vivo system [12], with frequencies of closer to 1%
being more typical. In our system, transposition occurs at
such high frequencies that selection for transgene inser-
Protocol for use of transgene insertion plasmid Figure 2
Protocol for use of transgene insertion plasmid. 1) 
Transform the plasmid into the strain of choice and select 
transformants on LB + ampicillin at 32°C. Introduction of the 
plasmid by conjugation is also an option. 2) Streak once to 
ensure that the cells are carrying the plasmid, then grow 
non-selectively in LB at 32°C. In all strains tested thus far, 
leaky expression of TnsABCD during this step has been suffi-
cient to allow site-specific transposition into the attTn7, but 
0.1% arabinose may be added to increase levels of expression 
of TnsABCD. 3) Plate cells at 42°C to block replication of 
the plasmid. 4) Streak once at 42°C to ensure loss of the 
plasmid, then verify insertions in the attachment site by PCR.
transform
select ampicillin
resistance at 32°C
grow non-selectively 
Tn7 transposes
site-specifically
verify insertion by PCR
Plate on LB at 42°C
to block plasmid 
replication BMC Microbiology 2006, 6:39 http://www.biomedcentral.com/1471-2180/6/39
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tion is not required. This is not the first system to employ
Tn7  for transgene integration. However, previously
described systems utilize multiple plasmids and are not
efficient enough to allow detection of insertion events in
the absence of a selection [14-16]. Non-specific transposi-
tion occurs at a frequency of 6.8 × 10-5 in our system
(Table 2), indicating that there is little worry of non-spe-
cific or secondary transposition events. We have demon-
strated the utility of this system in ten members of the E.
coli reference collection of environmental isolates (data
not shown) [17] and others have successfully inserted
transgenes into Enteropathogenic and Enterohemorrhagic
E. coli isolates (R. Keller, J.W. Yoon and J. Kaper, personal
communication). We have also demonstrated the utility
of this system in another Enterobacterial species, Salmo-
nella typhimurium (data not shown) indicating the broad
utility of our approach. Our transgene integration method
can be used in any bacterium that supports replication of
the pSC101 origin (i.e., members of the E. coli, Salmo-
nella, or Shigella families).
This transgene integration system accommodates large
transgenes, as we have seen similar frequencies of inser-
tion with inserts as large as 3.2 kb (data not shown). Oth-
ers have used pGRG25 to insert the 7.1 kb luxCDABE
operon into Extraintestinal pathogenic E. coli and
observed similar insertion frequencies (P. Germon, per-
sonal communication). It is likely to be possible to insert
even larger transgenes, as wildtype Tn7  carries 14 kb
between the left and right ends.
Because the Tn7  attachment site is highly conserved
amongst diverse bacterial species [18] this system may be
useful in many different bacteria. Possible limitations of
the system with regard to whether it will work in other
organisms are: 1) the ability to deliver DNA via transfor-
mation or conjugation, 2) the ability of the plasmid to be
replicated sufficiently to support transposase expression,
and 3) the activity of the araBAD promoter driving trans-
posase expression. Restriction of foreign DNA can have a
dramatic negative effect on transformation efficiency,
however in cases where restriction may be a problem, for
example, with environmental isolates, the Ocr type 1
restriction inhibitor [19] (Epicentre Biotechnologies) can
greatly improve transformation efficiency. Systems utiliz-
ing broad host range plasmids have been described that
use Tn7 transposition functions to insert transgenes into
the chromosome (e.g. [14]) in numerous different bacte-
ria. Although these other systems work in diverse bacteria
and are very useful tools for that reason, they have more
components and are several orders of magnitude less effi-
cient requiring drugR markers to detect transgene inser-
tions. The drugR marker can be removed after insertion
with additional steps, but clearly the system we describe
here for single-step insertion without selection is simpler
and easier in the organisms where we have demonstrated
functionality (E.coli/Salmonella/Shigella).
Expanding the utility of our system to include bacteria
outside the Enterobacteriaceae might be possible by
incorporating a broad host range replicon combined with
a negative selection for loss of the plasmid. Indeed, Tn7
seems the ideal molecular machine for delivering trans-
genes given that the attTn7 sequence appears to be present
in most genomes examined (it occurs twice in some, but
this can be dealt with as in [14]). Tn7 has been demon-
strated to move in a broad variety of Gram negative bacte-
ria [9] and the presence of Tn7-like sequences in Bacillus
cereus and Clostridium thermocellum suggests that it would
transpose in Gram positives as well ([20] and GenBank
accession #NZ_AABG04000054).
A commonly used method for transgene insertion availa-
ble prior to this work [4] is based on phage λ red recombi-
nation. It usually requires PCR amplification of the
substrate, transformation of the red gam expression system
and transformation of the recombination substrate, fol-
lowed by curing and PCR verification. Removal of the nec-
essary drugR marker requires an additional transformation
and curing. It works at frequencies at or below 10-6, mean-
ing that a selection is required. The Tn7-based method
described here inserts genes at such high frequencies that
selection is not required. It requires very few steps: cloning
the transgene, transformation into the strain of interest
and growth at 2 temperatures, followed by PCR verifica-
Table 1: Frequency of transgene insertion at E. coli attTn7 in the 
absence of selection. For each experiment shown three 
independent electrotransformations of pGRG25, which carries 
the multiple cloning site as the transgene, into strain MG1655 
were performed. One single colony from each transformation 
was streaked out once at 32°C on LB with ampicillin, and then a 
culture of each colony was grown overnight in LB at 32°C. 
Appropriate dilutions were then plated on LB at 42°C. Ten 
colonies from each culture were examined by PCR to determine 
if they carried an insertion at the attachment site. The values 
shown are the average frequency from 3 cultures with 10 
colonies examined per culture (i.e., a total of 30 colonies 
examined per experiment). The final value shows a mean 
average of all 6 experiments and the standard error of the mean 
(SEM).
Experiment Frequency of colonies carrying 
Tn7 at attachment site
1 0.83
2 0.70
3 0.63
4 0.70
5 0.90
6 0.97
Average ± SEM 0.79 ± 0.05BMC Microbiology 2006, 6:39 http://www.biomedcentral.com/1471-2180/6/39
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tion of insertion. Clearly our system is an improved
method with fewer steps and greatly improved efficiency.
We anticipate this system to be useful for studies requiring
single-copy gene expression, for example genetic studies,
including complementation experiments. In addition, we
envision that this system will be useful for development of
bacterial strains for environmental release (that may not
have antibiotic-resistance markers), including live-vector
vaccine strains [2]. Expression of heterologous antigens in
vaccine strains is currently largely plasmid-based, one rea-
son being that plasmid copy number facilitates expression
of sufficient antigen to engender an immune response.
However, recent work has demonstrated that immunolog-
ically relevant levels of antigen can be expressed from the
chromosome [21]. The construction of stable and selec-
tion-free chromosomal transgenes using this Tn7-based
system should support the development of chromosomal
antigen expression technology. It is worth noting that
because Tn7  recognizes an attTn7  site in the human
genome [18] it may be possible to create vectors for use in
human cells to deliver genes at high-frequency into an
innocuous site in the human genome for gene therapy.
Methods
Vector construction
Plasmid pCW4 [22], containing tnsABCD, was digested
with PacI and partially digested with DrdI, to liberate a
6636 bp PacI-DrdI fragment. The overhanging ends were
made blunt with Klenow fragment and ligated to SmaI lin-
earized pBAD18 [10]. The plasmid containing tnsABCD in
the correct orientation relative to the PBAD promoter was
named pGRG2. pGRG2 and pMAK700 [11], a pSC101
plasmid with a temperature-sensitive replicon, were
digested with NaeI, releasing a 9541 bp tnsABCD contain-
ing fragment and a 2416 bp pSC101 origin-containing
fragment, respectively. These two fragments were ligated
together to create pGRG3, which contains the bla gene
encoding β-lactamase, the araC gene and the PBAD-tnsA-
BCD genes, and the temperature-sensitive pSC101 origin
of replication. KanR and ChlR mini-Tn7s were inserted into
pGRG3 using red-gam  recombination as follows: The
primers
ATCATGGCAATTCTGGAAGAAATAGCGCTTTCAGCCtgt-
gggcggacaaaatagttgggaactggga and
CATGAGCAGATCCTCTACGCCGGACGCATCGTGGCCt-
gtgggcggacaataaagtcttaaactgaa were used to amplify the
KanR mini-Tn7  from pGPS1.1 and the ChlR  mini-Tn7
from pGPS2.1 (both from New England Biolabs). The
lower case letters are complementary to Tn7 and the upper
case letters are homologous to sequences in pGRG3. The
resulting PCR products were transformed into DH5α car-
rying the plasmid pTP223 [23], which expresses the phage
λ  red  recombinase products, and KanR or ChlR recom-
binants were selected. The resulting KanR and ChlR mini-
Tn7  containing plasmids were named pGRG8 and
pGRG6. Both Tn7 inserts in the plasmids were sequenced
to ensure that no mutations were inserted by PCR. Any
mutations were corrected to the wildtype sequence by
subcloning from samples that did not contain those
mutations. pGRG17 was created by digesting pGRG8 with
DraIII and EagI to remove the kanamycin resistance gene.
This was replaced with the annealed oligonucleotides
GGCCGTGGCGCGCCTCCTAGGTGCTCGAGTGGCG-
GCCGCTATTGAGGGATCTGATTAATTAAAAC and
TTAATTAATCAGATCCCTCAATAGCGGCCGCCACTC-
GAGCACCTAGGAGGCGCGCCAC to create a multiple
cloning site with the following unique restriction sites:
AvrII, NotI, PacI, and XhoI.
To provide conjugation as an alternative way to introduce
these plasmids into bacterial strains, we cloned the oriT
site from the RP4 plasmid sequences in the strain SM10
[24].  oriT  was amplified by PCR using primers
GGCGCCGGCCAGCCTCGCAGAGCA and GGCGCCG-
GGCAGGATAGGTGAAGT, and cloned into pCR2.1-topo
using the Topo TA cloning kit (Invitrogen). The sequence
and transfer activity was confirmed, then the oriT
Table 2: Frequency of transgene insertion into sites other than attTn7. For each experiment shown, three independent 
electrotransformations of pGRG19 (carrying a ChlR transgene) into MG1655 and MG1655 attTn7::Tn7kan were done. The presence of 
the Tn7 at attTn7 prevents insertion events there and allows measurement of the frequency at which Tn7 can transpose to other sites 
as discussed in the text [13]. One single colony from each transformation was streaked out once at 32°C on LB with ampicillin. From 
this, a culture was grown overnight in LB at 32°C, and appropriate dilutions were plated at 42°C on LB and LB with chloramphenicol. 
Values shown are the frequency of ChlR
Strain Experiment Frequency of ChlR cells Average ± SEM
17 . 0  ×  1 0 -1
MG1655 2 7.2 × 10-1 (7.9 ± 0.8) × 10-1
39 . 4  ×  1 0 -1
16 . 8  ×  1 0 -5
MG1655 attTn7::Tn7 24 . 6  ×  1 0 -5 (5.5 ± 0.7) × 10-5
35 . 2  ×  1 0 -5BMC Microbiology 2006, 6:39 http://www.biomedcentral.com/1471-2180/6/39
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sequence was moved by moving the 113 bp SfoI fragment
into the NaeI site (resulting in the plasmid in parentheses)
of pGRG6 (pGRG19), pGRG8 (pGRG20), and pGRG17
(pGRG25). pGRG36 is identical to pGRG25, except that it
contains a SmaI site in the multiple cloning site. Both
pGRG25 and pGRG36 sequences can be downloaded at
GenBank using NCBI accession # DQ460223. The ability
of the delivery plasmids to be transferred by conjugation
was confirmed using pGRG25-containing SM10 as donor
in a standard conjugation assay at 32°C [25].
To facilitate the cloning of large fragments into the deliv-
ery vehicle we cloned the RfC.1 element from the Gateway
cloning system (Invitrogen) into the SmaI site of pGRG36,
yielding pGRG37. This allows in vitro movement of trans-
genes cloned in Gateway cloning vectors into pGRG37,
bypassing the need for standard cloning techniques [26].
Plasmid and strain handling
Plasmids and strains were prepared as described [27] with
the exception that transposition plasmids were grown in
LB medium with ampicillin and 0.1% glucose, to repress
transposition, and plasmids were prepared using Qiagen
very low-copy plasmid protocols.
Transformation and transposition protocol
E. coli electro-competent cells were prepared normally, as
described in [27], with the exception that they were grown
in Luria-Bertani (LB) medium with 0.1% glucose to
repress expression of the transposase during recovery.
Transformants were selected on LB + 100 µg/mL ampicil-
lin at 32°C and streaked out once, then grown overnight
in LB at 32°C, with no drugs present. Dilutions of this cul-
ture were plated on LB + 30 µg/mL chloramphenicol
(pGRG19) or on LB alone (pGRG25). Colonies were
streaked at least once at 42°C to ensure plasmid loss.
Transposition was verified by absence of the ampicillin
resistance marker and by PCR using the primers 5'GAT-
GCTGGTGGCGAAGCTGT and 5'GATGACGGTTTGTCA-
CATGGA, which flank the attTn7 site.
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